Kovet and Royal Canin Partner to Enhance Veterinary Diagnostics with AI-Powered Platform
HELSINKI, FINLAND – November 21, 2023 – Finnish Health Tech company Kovet and royal Canin have announced a collaboration to integrate Kovet’s AI-based clinical decision support tools with Royal Canin’s veterinary network. The partnership aims to improve diagnostic accuracy, clinic efficiency, and ultimately, pet health.
the collaboration will initially launch as a pilot project, with a worldwide market launch slated for the fourth quarter of 2025 and full market extension in 2026.Kovet’s platform assists veterinarians and their teams in making informed clinical decisions thru AI-driven analysis.
“This cooperation reflects our common vision of supporting veterinarians with smart tools that facilitate clinical decision-making and improve the standard of treatment,” said Dr. Johanna Relatives, CEO of Kovet.
Royal Canin intends to leverage Kovet’s technology to further its mission of improving pet health through science and partnerships. “We at Royal Canin want to support veterinarians and their teams with the best available tools. The platform from KKOVET is perfectly in line with our mission to improve the health of pets through science and partnerships. We are pleased to be able to make this solution more clinics available to achieve our goal: a better world for pets,” stated Dr. Brent Mayabb, Global Chief Medical Officer at Royal Canin.
Kovet currently serves thousands of clinics globally, aiding veterinarians in faster and more precise diagnoses. royal Canin,a part of Mars Incorporated,is a global leader in pet health nutrition,founded in 1968 by French veterinarian Dr. Jean Cathary.
The companies emphasize that the original language publication is the legally valid version,and translations are provided for improved dialog.
